Tomorrow’s Medical Cannabis Track Keynote Talk
September 13—Baltimore, Maryland— Dr. Dustin Sulak, co-founder of Healer, will give a keynote talk tomorrow in the medical cannabis meeting room 314–315 at 10:00 a.m. The talk is titled “Cannabis in Integrative Medicine, Health Promotion, and Disease Prevention.”
Dr. Dustin Sulak, co-founder of Healer, will give a keynote talk tomorrow in the medical cannabis meeting room 314–315 at 10:00 a.m. The talk is titled “Cannabis in Integrative Medicine, Health Promotion, and Disease Prevention.”
Increasing evidence supports the vast therapeutic potential of cannabinoids applied in a conventional medical model. Clinicians and patients experienced in the use of herbal cannabis, however, know that cannabis is much more than a drug, and that its full therapeutic potential is not realized when it’s simply used like a pharmaceutical. In this presentation, Dr. Sulak will use the principles of integrative medicine to illustrate how cannabis can be used holistically to both treat and prevent disease, improve quality of life, and promote health, including individualized dosing plans, practical applications of natural cannabinoid acids, and therapeutic psychoactivity.
Dustin Sulak is an integrative osteopathic physician, leader in the emerging field of cannabinoid medicine, and author of Handbook of Cannabis for Clinicians: Principles and Practice. His clinical practice focuses on treating refractory conditions in adults and children. Dr. Sulak received undergraduate degrees in nutrition science and biology from Indiana University, and a doctorate of osteopathy from the Arizona College of Osteopathic Medicine. Dr. Sulak is the co-founder of Healer.com, a cannabis and wellness education resource.
For more information on the medical cannabis track, please visit the 2021 Cannabis Science Conference East Final Program & Exhibitor Guide.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
